BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28801646)

  • 1. A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Ho SY; Hou MC; Huo TI
    Sci Rep; 2017 Aug; 7(1):7914. PubMed ID: 28801646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinoma.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Al Juboori A; Lee RC; Lin HC; Huo TI
    Liver Int; 2016 Oct; 36(10):1498-506. PubMed ID: 26972815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
    Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
    World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma.
    Ho SY; Hsu CY; Liu PH; Hsia CY; Lei HJ; Huang YH; Ko CC; Su CW; Lee RC; Hou MC; Huo TI
    Liver Int; 2020 Jan; 40(1):205-214. PubMed ID: 31505104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.
    Hsu CY; Liu PH; Ho SY; Huang YH; Lee YH; Chiou YY; Hsieh TH; Fang T; Tsai YJ; Hou MC; Huo TI
    PLoS One; 2017; 12(11):e0188031. PubMed ID: 29125877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.
    Hsu CY; Liu PH; Ho SY; Hsia CY; Kudaravalli P; Lee YH; Chiou YY; Tsai YJ; Huang YH; Huo TI
    BMC Cancer; 2018 Mar; 18(1):289. PubMed ID: 29540157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Lin HC; Huo TI
    Ann Surg Oncol; 2016 Mar; 23(3):994-1002. PubMed ID: 26487000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
    J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
    Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
    Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
    Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
    Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
    He CB; Lao XM; Lin XJ
    Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    Kim CG; Lee HW; Choi HJ; Lee JI; Lee HW; Kim SU; Park JY; Kim DY; Ahn SH; Han KH; Kim HS; Kim KH; Choi SJ; Kim Y; Lee KS; Kim GM; Kim MD; Won JY; Lee DY; Kim BK
    Cancer Med; 2019 Sep; 8(11):5023-5032. PubMed ID: 31290618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study.
    Zang Y; Long P; Wang M; Huang S; Chen C
    Future Oncol; 2021 Dec; 17(36):5053-5066. PubMed ID: 34676798
    [No Abstract]   [Full Text] [Related]  

  • 17. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
    Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
    Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery.
    He W; Peng B; Tang Y; Yang J; Zheng Y; Qiu J; Zou R; Shen J; Li B; Yuan Y
    Clin Gastroenterol Hepatol; 2018 May; 16(5):756-764.e10. PubMed ID: 29246702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
    Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
    J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
    Heinrich S; Sprinzl M; Schmidtmann I; Heil E; Koch S; Czauderna C; Heinrich B; Philippe P Diggs L; Wörns MA; Kloeckner R; Galle PR; Marquardt JU; Weinmann A
    United European Gastroenterol J; 2020 May; 8(4):444-452. PubMed ID: 32213028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.